Author

Jan Verheijen

Mayo ClinicORCID 0000-0003-0481-9649Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Research Focus:database / resource· 1

Frequent Co-Authors

Aastha Gandhi· 1 shared Alice E. DavidsoniD· 1 shared Ana Lisa Taylor TavaresiD· 1 shared Andrew C. GilesiD· 1 shared Anna B Verwillow· 1 shared Anne GregoriD· 1 shared Annemieke M Aartsma-RusiD· 1 shared Aubrie SoucyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aastha Gandhi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Consensus guidelines for eligibility assessment of pathogenic variants to antisense oligonucleotide treatments

David Cheerie, Margaret M. Meserve, Danique Beijer, Charu Kaiwar, Logan Newton, Ana Lisa Taylor Tavares, Aubrie Soucy, Emma Sherrill, Stefanie Leonard, Stephan Sanders, Emily J. Blake, Nour M. Elkhateeb, Aastha Gandhi, Nicole Si Yan Liang, J. Morgan, , Marlen C. Lauffer

The paper presents consensus guidelines for assessing pathogenic variants' eligibility for antisense oligonucleotide treatments, including classification criteria and considerations for different therapeutic approaches.

The American Journal of Human Genetics · Mar 26, 2025Peer-reviewedGenetic & Genomic Medicine